Answers are grounded in this paper and cite their sources.
Myricetin (Myr) and Bergapten (Ber) are two potential anticancer flavonoids.The current study aimed to find out whether the flavonoids Myr and Ber have breast cancer-preventive and therapeutic potential.Myr and Ber separately showed an IC 50 of 50 µM against MDA-MB-231 (breast cancer) cells while having no discernible impact on normal HEK-293 cells.When compared to untreated cells, Myr and Ber significantly increased the production of free radicals, induced chromatin condensation, early and late apoptosis in MDA-MB-231 cells at respective IC 50 doses (50 µM).Overall results indicated that Myr and Ber displayed cytotoxicity by reactive oxygen species (ROS) dependent and triggered apoptosis in breast cancer cells.Considering the results of the present study, it is possible to conclude that Myr and Ber possess significant biological activity that would help in increasing the repertoire of effective anticancer drugs with better potency.
No takes yet. Share an insight, caveat, or question.
Trivedi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: